Dialysis Equipment in Texas

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. The company specializes in hemodialysis concentrates and related solutions for patients with end-stage kidney disease (ESKD). Rockwell Medical's product portfolio includes hemodialysis concentrates and Triferic (ferric pyrophosphate citrate), an iron replacement therapy. The company serves dialysis centers and renal care providers globally, focusing on reliability, quality, and customer service. Rockwell Medical emphasizes long-term innovation strategies to enhance product efficacy, manufacturing processes, and clinical outcomes for vulnerable patient populations dependent on hemodialysis therapy. The company is recognized for unmatched reliability and comprehensive customer support, with operations including manufacturing, distribution, and technical support for dialysis facilities.

AOSS Medical Supply, Inc. is a US-based distributor and manufacturer of medical supplies and consumables specializing in plasma collection, dialysis, and clinical laboratory products. The company operates an FDA-certified kit packing facility and offers customized nursing and medical school kits. Primary product lines include blood collection tubes (BD Vacutainer, BD Microtainer), fistula needles for arteriovenous fistulas (JMS products), dialysis supplies and accessories, plasma collection solutions, laboratory consumables, personal protective equipment (PPE), and wound care products. AOSS serves diverse markets including dialysis centers, plasma collection facilities, clinical laboratories, EMS providers, dental practices, tattoo studios, educational institutions, food and beverage, spa, and janitorial sectors. The company emphasizes bulk order discounts, fast and secure shipping (2–3 day processing, 5–7 day delivery domestically), customer service support, and satisfaction guarantees. Leadership includes CEO Eric Liew and COO/President Linda Liew. AOSS maintains quality focus and offers products meeting FDA approval standards. The company handles physician license verification for restricted products and provides 30-day returns (excluding PPE items). No specific regulatory certifications (510(k), ISO 13485, CE marking) are explicitly stated on the site, though FDA-certified kit packing capability is mentioned.

Footprint Medical Incorporated is a neonatal-focused medical device company specializing in peripherally inserted central catheter (PICC) insertion products and related neonatal interventional supplies. Based in San Antonio, Texas, the company manufactures and distributes products designed for critically ill neonates and infants in intensive care settings. Their product portfolio includes PICC insertion trays and accessories, umbilical catheters, urinary drainage systems, and enteral feeding solutions—all designed specifically for the unique anatomical and clinical requirements of premature and vulnerable newborns. The company markets its offerings as purpose-built neonatal solutions supporting vascular access, fluid management, and nutritional support in NICU environments. Footprint Medical operates a direct-to-hospital model supplemented by specialty distributor partnerships, allowing regional flexibility in market reach. The company emphasizes clinical training and education, offering PICC insertion training programs to nursing and clinical staff. Business operations center on a 5-day work week in San Antonio, with established distribution and customer support infrastructure. While specific regulatory credentials are not detailed on the accessible site pages, neonatal medical devices of this nature typically require FDA 510(k) clearance or equivalent regulatory approval. The company targets neonatal intensive care units and regional perinatal centers where specialized vascular access and feeding support are critical clinical requirements.

Laminate Medical Technologies develops specialized medical devices for arteriovenous fistula (AVF) management in hemodialysis patients. The company's flagship product is the VasQ™ Extravascular Support, designed to improve AVF function and durability. VasQ™ received FDA Transitional Pass-Through (TPT) Payment designation as of October 2024, indicating recognition as a breakthrough technology offering clinically meaningful advantages for patients requiring renal replacement therapy. The device addresses a significant clinical need in the dialysis population, where AVF maturation failure and stenosis remain common complications. Laminate operates with a global focus on improving outcomes for hemodialysis-dependent patients worldwide.